# Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

> **NCT03839680** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 60 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **PROCEDURE:** Endoscopy

## Key facts

- **NCT ID:** NCT03839680
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-01
- **Primary completion:** 2019-04-15
- **Final completion:** 2019-04-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03839680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03839680, "Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03839680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*